Ironwood Pharmaceuticals IRWD Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $106.51M+159% | $47.71M-47.3% | $122.06M+33.3% | $85.24M-9.7% | $41.14M-45.1% | ||
| $21.94M-20.0% | $21.86M-13.9% | $22.47M-24.7% | $23.37M-23.1% | $27.43M+6.3% | ||
| $12.03M-50.4% | $19.29M-42.6% | $21.91M-39.3% | $16.8M-54.6% | $24.26M-35.5% | ||
| $33.93M-51.7% | $40.9M-30.7% | $46.58M-29.4% | $39.92M-42.5% | $70.25M+10.0% | ||
| $72.57M+349% | $6.81M-78.4% | $75.48M+194% | $45.32M+81.5% | -$29.11M-364% | ||
| 68.1%+139pp | 14.3%-20.5pp | 61.8%+33.9pp | 53.2%+26.7pp | -70.7%-85.5pp | ||
| $9.14M+13.3% | $7.89M-11.5% | $8.43M-10.5% | $8.36M+11.9% | $8.07M+11.6% | ||
| $1.7M+95.4% | $1.46M+87.5% | $930K-19.3% | $818K-40.2% | $869K-25.7% | ||
| -$7.4M-3.3% | -$6.35M+15.3% | -$7.46M+9.7% | -$7.5M-22.9% | -$7.16M-18.2% | ||
| $65.17M+280% | $455K-98.1% | $68.02M+292% | $37.82M+100% | -$36.27M-832% | ||
| $24.4M+2,090% | $2.73M-87.4% | $27.94M+104% | $14.22M-27.9% | $1.11M-87.8% | ||
| $40.77M+209% | -$2.28M-201% | $40.08M+999% | $23.6M+2,844% | -$37.39M-798% | ||
| 38.3%+129pp | -4.8%-7.3pp | 32.8%+28.9pp | 27.7%+28.6pp | -90.9%-85.3pp | ||
| $0.24+204% | -$0.01-200% | $0.23+1,050% | $0.14+1,500% | -$0.23-667% | ||
| $0.25+209% | -$0.01-200% | $0.25+1,150% | $0.15+1,600% | -$0.23-667% | ||
| 166.7M+3.6% | 163M+1.8% | 177.8M+10.9% | 176.8M+11.2% | 161M+2.1% | ||
| 163.5M+1.5% | 161.8M+1.7% | 162.2M+1.6% | 161.7M+1.7% | 161M+2.1% | ||
| $19.2M+2,765% | $0-100% | $27.77M+262% | $14.11M+6.4% | $670K-88.9% | ||
| $443K-7.5% | $460K-5.2% | $475K-6.3% | $467K-7.7% | $479K-6.6% | ||
| -$106K-1,414% | —— | -$26K0.0% | -$647K-1,169% | -$7K-129% | ||
| —— | $885.75K-57.9% | $885.75K-57.9% | $885.75K-57.9% | $885.75K-57.9% | ||
| -$4.89M-151% | $0+100% | $10.69M— | -$13.84M-592% | $9.66M+177% | ||
| $59.1M+240% | -$73.62M— | $34.19M— | $46.4M+434% | -$42.12M+26.2% | ||
| -$621K-8.6% | -$612K-8.9% | -$603K-8.8% | -$584K-8.8% | -$572K-9.4% | ||
| -$219K-217% | $0+100% | $249K-94.4% | $3.67M-36.5% | $187K-84.0% | ||
| -$121K+14.2% | -$100K— | -$63K— | -$143K-114% | -$141K-370% | ||
| -$6M-1,573% | -$1.09M+52.1% | $248K— | $64K— | $407K-84.4% | ||
| —— | $7.58M-6.8% | $7.58M-6.8% | $7.58M-6.8% | $7.58M-6.8% | ||
| $1.7M+95.4% | $1.46M+87.5% | $930K-19.3% | $818K-40.2% | $869K-25.7% | ||
| —— | $122K+101% | $0+100% | $88K+100% | $6K+100% | ||
| —— | $0— | -$2K+87.5% | -$2K+96.6% | -$31K+54.4% | ||
| $5.12M-74.3% | $74.58M+390% | $47.58M+381% | —— | $19.95M-55.6% | ||
| $444K+8.6% | $435K+8.2% | $426K+8.4% | $418K+8.6% | $409K+8.2% | ||
| $42K+13.5% | $77K-51.9% | $40K-75.0% | $39K-75.6% | $37K-76.9% | ||
| —— | $0— | $2K-87.5% | $2K-96.6% | $31K-54.4% | ||
| —— | $122K-39.9% | $0— | $88K-88.3% | $6K-99.9% | ||
| -$40K-100% | $0-100% | $2.2M+13,650% | -$250K-112% | $18.56M+4,147% | ||
| $106.51M+159% | $47.71M-47.3% | $122.06M+33.3% | $85.24M-9.7% | $41.14M-45.1% | ||
| $3.65M-31.0% | $3.82M-16.3% | $3.61M-56.6% | $4.52M-47.2% | $5.29M-36.9% | ||
| $72.57M+349% | $6.81M-78.4% | $75.48M+194% | $45.32M+81.5% | -$29.11M-364% | ||
| $73.02M+355% | $7.27M-77.1% | $75.96M+193% | $45.79M+81.1% | -$28.63M-353% | ||
| $73.02M+355% | $7.27M-77.1% | $75.96M+193% | $45.79M+81.1% | -$28.63M-353% | ||
| 68.6%+138pp | 15.2%-19.9pp | 62.2%+33.9pp | 53.7%+26.9pp | -69.6%-84.7pp | ||
| $72.57M+349% | $6.81M-78.4% | $75.48M+194% | $45.32M+81.5% | -$29.11M-364% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Ironwood Pharmaceuticals's revenue?
- Ironwood Pharmaceuticals (IRWD) generated $361.5M in revenue over the trailing twelve months, up 13.8% year over year.
- Is Ironwood Pharmaceuticals profitable?
- Ironwood Pharmaceuticals reported $102.2M in net income over the trailing twelve months, a 28.3% net margin.
- What are Ironwood Pharmaceuticals's profit margins?
- Gross margin is 99.2% and operating margin is 55.4%, with a 28.3% net margin.
- What is Ironwood Pharmaceuticals's earnings per share?
- Ironwood Pharmaceuticals's diluted EPS over the trailing twelve months is $0.60.
- Where does Ironwood Pharmaceuticals's income statement data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
